SG Americas Securities
IMCR icon

SG Americas Securities’s Immunocore IMCR Stock Holding History

SG Americas Securities’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,078
Closed -$213K – 3517
2026
Q1 		$213K Sell
7,078
-1,581
-18% -$51.1K ﹤0.01% 2604
2025
Q4 		$301K Buy
8,659
+1,067
+14% +$37.7K ﹤0.01% 2753
2025
Q3 		$276K Buy
7,592
+4,325
+132% +$147K ﹤0.01% 2548
2025
Q2 		$103K Buy
+3,267
New +$101K ﹤0.01% 2625
2025
Q1 		– Sell
-8,827
Closed -$260K – 3595
2024
Q4 		$260K Buy
8,827
+27
+0.3% +$854 ﹤0.01% 1917
2024
Q3 		$274K Sell
8,800
-151,558
-95% -$5.51M ﹤0.01% 2229
2024
Q2 		$5.43M Buy
160,358
+152,207
+1,867% +$7.76M 0.03% 509
2024
Q1 		$530K Sell
8,151
-4,418
-35% -$303K ﹤0.01% 1395
2023
Q4 		$859K Buy
12,569
+5,720
+84% +$297K 0.01% 1107
2023
Q3 		$355K Buy
6,849
+129
+2% +$7.63K ﹤0.01% 1983
2023
Q2 		$403K Buy
6,720
+268
+4% +$15.3K ﹤0.01% 1495
2023
Q1 		$319K Buy
6,452
+191
+3% +$10.7K ﹤0.01% 2082
2022
Q4 		$357K Buy
+6,261
New +$352K ﹤0.01% 1789

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SG Americas Securities's IMCR Position: Q2 2026 in Review

SG Americas Securities sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 7,078 shares — an estimated $213K sold.

SG Americas Securities first reported a position in IMCR in Q4 2022 and held it in 13 quarters. The position peaked at $5.43M in Q2 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • SG Americas Securities reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 7,078 Immunocore shares in Q2 2026, an estimated $213K.
  • SG Americas Securities first reported a position in Immunocore in Q4 2022 and held it in 13 quarters.
  • SG Americas Securities's Immunocore position peaked at $5.43M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.